Details
Stereochemistry | RACEMIC |
Molecular Formula | C7H15Cl2N2O4P |
Molecular Weight | 293.085 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OO[C@@H]1CCO[P@](=O)(N1)N(CCCl)CCCl
InChI
InChIKey=VPAWVRUHMJVRHU-VGDKGRGNSA-N
InChI=1S/C7H15Cl2N2O4P/c8-2-4-11(5-3-9)16(13)10-7(15-12)1-6-14-16/h7,12H,1-6H2,(H,10,13)/t7-,16-/m1/s1
Perfosfamide is the active metabolite of the nitrogen mustard cyclophosphamide with potent antineoplastic and immunosuppressive properties. Perfosfamide alkylates DNA, thereby inhibiting DNA replication and RNA and protein synthesis. The incubation of normal human marrow cells with perfosfamide has a toxic effect on granulocyte-macrophage progenitor cells that is dose as well as white blood cell concentration dependent. It is likely that this dependency of the perfosfamide stem cell effect is caused not only by the target white blood cell concentration but by the suspension’s total protein concentration. Autologous bone marrow transplantation with perfosfamide purging in patients with acute myeloid leukemia in second complete remission produced results similar to that reported with allogeneic bone marrow transplantation. Perfosfamide had been in phase III clinical trial for the treatment of acute myeloid leukemia. However, this development was discontinued.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds. | 1981 Jun |
|
Immediate hypersensitivity reaction to cyclophosphamide. | 1994 Jul |
|
De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. Elevated class 1 ALDH activity is closely correlated with reduction in DNA interstrand cross-linking and lethality. | 1996 May 17 |
|
Cyclophosphamide enhances TNF-alpha-induced apoptotic cell death in murine vascular endothelial cell. | 2006 Mar 6 |
|
Teratogen-induced activation of p53 in early postimplantation mouse embryos. | 2007 Jan |
|
RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide. | 2007 Jan |
|
Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion. | 2007 Jul |
|
4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG. | 2008 Feb |
|
The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide. | 2008 May |
|
Teratogen responsive signaling pathways in organogenesis stage mouse limbs. | 2009 Apr |
|
Effects of exposure to a DNA damaging agent on the hypoxia inducible factors in organogenesis stage mouse limbs. | 2012 |
|
The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. | 2012 Jan 5 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C697
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
||
|
FDA ORPHAN DRUG |
37789
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB09724MIG
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
181815
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
62435-42-1
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
3430
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL61511
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
Perfosfamide
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
C1423
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
m8546
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | Merck Index | ||
|
DD-5
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
6687
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
9554809
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
39800-16-3
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
C011272
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
DB12727
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
U880A4FUDA
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
100000082751
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY | |||
|
DTXSID2049058
Created by
admin on Fri Dec 15 17:52:48 GMT 2023 , Edited by admin on Fri Dec 15 17:52:48 GMT 2023
|
PRIMARY |
ACTIVE MOIETY